688298 东方生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资17,152-2.68%17,62520,41821,23521,039
投资性房地产0--0000
固定资产1,575,727-1.93%1,606,6811,541,0561,408,477671,746
在建工程1,021,3851.16%1,009,6841,134,471796,483369,990
无形资产866,710-1.94%883,878690,907478,814481,239
商誉0--0000
其他非流动资产373,7342.44%364,823728,963394,684412,244
3,854,708-0.72%3,882,6904,115,8163,099,6941,956,258

流动资产
货币资金2,250,746-8.12%2,449,7273,081,4974,164,7366,596,975
应收账款177,820-16.54%213,059228,082206,163309,357
存货293,915-5.15%309,863308,961346,775431,919
其他流动资产315,86211.37%283,607360,2251,178,5821,409,230
3,038,343-6.69%3,256,2563,978,7655,896,2578,747,481

流动负债
短期借款134,9633.38%130,555116,779198,2220
应付票据30,995326.99%7,259025,760518,095
应付帐款355,669-24.99%474,146515,489574,7261,061,974
其他流动负债280,69327.64%219,903571,533287,079698,412
802,319-3.55%831,8631,203,8021,085,7872,278,481
流动资产净值2,236,023-7.77%2,424,3932,774,9634,810,4696,469,000
资产总额减流动负债6,090,732-3.43%6,307,0836,890,7797,910,1648,425,259

非流动负债
长期借款45,015-71.69%158,9900300,00050,000
应付债券0--0000
其他非流动负债60,841-2.53%62,41899,34660,43652,265
105,856-52.19%221,40899,346360,436102,265

总权益
    实收股本201,6000.00%201,600201,600201,600168,000
    储备项目5,692,408-1.70%5,791,1166,443,4917,234,4717,994,846
股东权益5,894,008-1.65%5,992,7166,645,0917,436,0718,162,846
非控股权益90,868-2.25%92,959146,342113,657160,149